11:41 AM EST - Theralase Technologies Inc. : announced today that the Theralase therapeutic laser system, has been proven clinically effective in the treatment of tobacco addiction. The Theralase technology was clinically evaluated on over 500 subjects, who were heavy smokers, to validate if they were able to reduce their smoking by at least 25%, 30 days after receiving the Theralase laser treatment. The results of the clinical study demonstrated that 405 (73.8%) subjects had reduced their consumption of tobacco products by 25% or more, with 373 (92.0%) completely eliminating use and 32 of those subjects (8.0%) showing a reduction of at least 25%. Theralase Technologies Inc.
shares V.TLT are trading unchanged at $0.20.
